Nebraska Ebola Patient Getting Same Experimental Drug as Texas Patient
October 7, 2014
(ABC News) – The American journalist who is being treated for Ebola at a Nebraska hospital is receiving the same experimental treatment as the Liberian patient who was diagnosed with the disease in Texas. “After looking at the data on this drug, collaborating with the CDC and FDA and speaking with the patient and his family, we decided this was currently our best option for treatment,” said Dr. Phil Smith, the medical director of the biocontainment unit at Nebraska Medical Center where Ashoka Mukpo is being treated.